BIO President & CEO John F. Crowley released the following statement: “A healthy and prosperous society is vitally important to the American people and to the world. The public health, economic ...

BIO strongly supports a manufacturer’s ability to use a 340B rebate as an appropriate option to make 340B pricing available to covered entities. "Manufacturers should have the choice to effectuate ...

WASHINGTON – BIO President & CEO John F. Crowley released the following statement on the results of the 2024 U.S. election: “We look forward to working closely with President-elect Trump, his incoming ...

Today, we explore BIO’s recommendations for how CMS can safeguard patient access under Medicare Part D, along with insights on a California Supreme Court case that could affect the complex drug ...

A collaborative initiative to advance corporate board diversity through partnerships and more.

At its simplest, biotechnology is technology based on biology - biotechnology harnesses cellular and biomolecular processes to develop technologies and products that help improve our lives and the ...

The Biotechnology Innovation Organization (BIO) is the world’s largest trade association representing the life sciences industry. BIO members are leading the research and development of innovative ...

Apply today to join an unparelled network of BIO Members and to benefit from a number of resources and event discounts. BIO membership is available only to bona fide organizations that promote ...

Explore the webinar opportunities for interactive, online learning about emerging issues in biotechnology public policy, scientific progress, and raising capital, plus methods to benefit from BIO’s ...

Thank you for being a member of BIO. Join the conversation and let everyone know you're a member using the resources below!

Prior to being appointed to this senior leadership position at the FDA, Anna served as the long-time health policy director and senior advisor to Sen. Richard Burr (R-NC) for all health care issues, ...

Jeff is a registered patent attorney and an intellectual property and innovation policy professional with a unique combination of training and real-world experience. Jeff has done policy work for ...